Antiplatelet therapy after complex percutaneous coronary intervention and in left main coronary disease. Not all lesions are the same.

Rev Esp Cardiol (Engl Ed)

Unidad de Hemodinámica, Servicio de Cardiología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain. Electronic address:

Published: April 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rec.2023.01.001DOI Listing

Publication Analysis

Top Keywords

antiplatelet therapy
4
therapy complex
4
complex percutaneous
4
percutaneous coronary
4
coronary intervention
4
intervention left
4
left main
4
main coronary
4
coronary disease
4
disease lesions
4

Similar Publications

Antiplatelet Agents in Endovascular Neurointerventional Procedures.

J Neurosurg Anesthesiol

January 2025

Department of Neurology, Neurocritical Care Division, University of Pennsylvania, Philadelphia, PA.

Minimally invasive, image-guided endovascular procedures are becoming increasingly prevalent as techniques and technologies have advanced, particularly within the realm of neurovascular interventions. Endovascular approaches ubiquitously result in endothelial injury with subsequent risk of thromboembolic complications. Periprocedural antiplatelet agent use is an integral component of the management of patients undergoing endovascular neurointerventional procedures.

View Article and Find Full Text PDF

 Perioperative management of antithrombotic agents may affect bleeding and lead to thromboembolic complications, but there is no consensus on optimal protocol in head and neck surgery.  To explore the effect of antithrombotic agents on postoperative bleeding.  We compared clinical characteristics, type of surgery, antithrombotic agents, continued use of medication or not, and frequency of postoperative bleeding among patients who were receiving antithrombotic therapy at the time of their decision to undergo surgery for head and neck malignancies, from 2008 to 2022.

View Article and Find Full Text PDF

Background: Intrasaccular devices have broadened treatment options for wide necked aneurysms. This study presents the preliminary experience with the Artisse 2.0 device.

View Article and Find Full Text PDF

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Hemodialysis: An International, Multicentric Registry.

JACC Clin Electrophysiol

January 2025

Cardioangiologisches Centrum Bethanien, Agaplesion Markus-Krankenhaus, Frankfurt am Main, Germany.

Background: The net benefit of oral anticoagulation in patients with end-stage renal disease on hemodialysis (HD) is uncertain. In recent years, left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulation; however, there is scant evidence of LAAC in patients on HD.

Objectives: This study aimed to assess the feasibility and safety of LAAC in patients on HD.

View Article and Find Full Text PDF

Objectives: Chronic Kidney Disease (CKD) has been associated with a prothrombotic state. CKD affects hemostasis through altered platelet function and coagulation factors. Traditional tests provide limited insight into these changes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!